1	Molecular	molecular	_	_	_	_	_	_	_
2	mechanisms	mechanism	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	neutrophil-endothelial	neutrophil-endothelial	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	adhesion	adhesion	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	redox	redox	_	_	_	_	_	_	_
10	imbalance	imbalance	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	implicated	implicate	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	intracellular	intracellular	_	_	_	_	_	_	_
9	thiols	thiol	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	nuclear	nuclear	_	_	_	_	_	_	_
15	factor-kappaB	factor-kappab	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	regulation	regulation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	endothelial	endothelial	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	adhesion	adhesion	_	_	_	_	_	_	_
23	molecules	molecule	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	designed	design	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	determine	determine	_	_	_	_	_	_	_
7	whether	whether	_	_	_	_	_	_	_
8	changes	change	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	endothelial	endothelial	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	glutathione	glutathione	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	GSH	GSH	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	oxidized	oxidize	_	_	_	_	_	_	_
18	glutathione	glutathione	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	GSSG	GSSG	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	can	can	_	_	_	_	_	_	_
23	alter	alter	_	_	_	_	_	_	_
24	neutrophil	neutrophil	_	_	_	_	_	_	_
25	adhesivity	adhesivity	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	define	define	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	molecular	molecular	_	_	_	_	_	_	_
31	mechanism	mechanism	_	_	_	_	_	_	_
32	that	that	_	_	_	_	_	_	_
33	underlies	underlie	_	_	_	_	_	_	_
34	this	this	_	_	_	_	_	_	_
35	GSSG/GSH-induced	gssg/gsh-induced	_	_	_	_	_	_	_
36	adhesion	adhesion	_	_	_	_	_	_	_
37	response	response	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	umbilical	umbilical	_	_	_	_	_	_	_
5	vein	vein	_	_	_	_	_	_	_
6	endothelial	endothelial	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	HUVEC	HUVEC	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	monolayers	monolayer	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	6	6	_	_	_	_	_	_	_
14	hours	hour	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	0.2	0.2	_	_	_	_	_	_	_
17	mmol/L	mmol/l	_	_	_	_	_	_	_
18	diamide	diamide	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	1	1	_	_	_	_	_	_	_
21	mmol/L	mmol/l	_	_	_	_	_	_	_
22	buthionine	buthionine	_	_	_	_	_	_	_
23	sulfoximine	sulfoximine	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	BSO	BSO	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	decreased	decrease	_	_	_	_	_	_	_
28	GSH	gsh	_	_	_	_	_	_	_
29	levels	level	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	increased	increase	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	ratio	ratio	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	GSSG	gssg	_	_	_	_	_	_	_
36	to	to	_	_	_	_	_	_	_
37	GSH	gsh	_	_	_	_	_	_	_
38	without	without	_	_	_	_	_	_	_
39	cell	cell	_	_	_	_	_	_	_
40	toxicity	toxicity	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	redox	redox	_	_	_	_	_	_	_
3	changes	change	_	_	_	_	_	_	_
4	are	be	_	_	_	_	_	_	_
5	similar	similar	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	those	those	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	anoxia/reoxygenation	anoxia/reoxygenation	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Diamide	Diamide	_	_	_	_	_	_	_
2	plus	plus	_	_	_	_	_	_	_
3	BSO-induced	bso-induced	_	_	_	_	_	_	_
4	thiol/disulfide	thiol/disulfide	_	_	_	_	_	_	_
5	imbalance	imbalance	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	associated	associate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	biphasic	biphasic	_	_	_	_	_	_	_
11	increase	increase	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	neutrophil	neutrophil	_	_	_	_	_	_	_
14	adhesion	adhesion	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	HUVECs	huvec	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	peak	peak	_	_	_	_	_	_	_
19	responses	response	_	_	_	_	_	_	_
20	observed	observe	_	_	_	_	_	_	_
21	at	at	_	_	_	_	_	_	_
22	15	15	_	_	_	_	_	_	_
23	minutes	minute	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	phase	phase	_	_	_	_	_	_	_
26	1	1	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	240	240	_	_	_	_	_	_	_
30	minutes	minute	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	phase	phase	_	_	_	_	_	_	_
33	2	2	_	_	_	_	_	_	_
34	)	)	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	N-Acetylcysteine	N-Acetylcysteine	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	attenuated	attenuate	_	_	_	_	_	_	_
4	neutrophil	neutrophil	_	_	_	_	_	_	_
5	adhesion	adhesion	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	both	both	_	_	_	_	_	_	_
8	phases	phase	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	which	which	_	_	_	_	_	_	_
11	indicated	indicate	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	role	role	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	GSH	GSH	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	adhesion	adhesion	_	_	_	_	_	_	_
19	responses	response	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Interestingly	interestingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	phase	phase	_	_	_	_	_	_	_
4	1	1	_	_	_	_	_	_	_
5	adhesion	adhesion	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	inversely	inversely	_	_	_	_	_	_	_
8	correlated	correlate	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	GSH	gsh	_	_	_	_	_	_	_
11	levels	level	_	_	_	_	_	_	_
12	but	but	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	GSSG/GSH	gssg/gsh	_	_	_	_	_	_	_
17	ratio	ratio	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	whereas	whereas	_	_	_	_	_	_	_
20	phase	phase	_	_	_	_	_	_	_
21	2	2	_	_	_	_	_	_	_
22	neutrophil	neutrophil	_	_	_	_	_	_	_
23	adhesion	adhesion	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	positively	positively	_	_	_	_	_	_	_
26	correlated	correlate	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	GSSG/GSH	gssg/gsh	_	_	_	_	_	_	_
29	ratio	ratio	_	_	_	_	_	_	_
30	but	but	_	_	_	_	_	_	_
31	not	not	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	GSH	gsh	_	_	_	_	_	_	_
34	levels	level	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Intercellular	intercellular	_	_	_	_	_	_	_
2	adhesion	adhesion	_	_	_	_	_	_	_
3	molecule-1	molecule-1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	P-selectin-specific	p-selectin-specific	_	_	_	_	_	_	_
6	monoclonal	monoclonal	_	_	_	_	_	_	_
7	antibodies	antibody	_	_	_	_	_	_	_
8	attenuated	attenuate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	increased	increase	_	_	_	_	_	_	_
11	neutrophil	neutrophil	_	_	_	_	_	_	_
12	adhesion	adhesion	_	_	_	_	_	_	_
13	during	during	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	phases	phase	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	whereas	whereas	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	anti-E-selectin	anti-e-selectin	_	_	_	_	_	_	_
20	monoclonal	monoclonal	_	_	_	_	_	_	_
21	antibody	antibody	_	_	_	_	_	_	_
22	also	also	_	_	_	_	_	_	_
23	attenuated	attenuate	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	phase	phase	_	_	_	_	_	_	_
26	2	2	_	_	_	_	_	_	_
27	response	response	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Pretreatment	Pretreatment	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	actinomycin	actinomycin	_	_	_	_	_	_	_
4	D	D	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	cycloheximide	cycloheximide	_	_	_	_	_	_	_
7	or	or	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	competing	compete	_	_	_	_	_	_	_
10	ds-oligonucleotides	ds-oligonucleotide	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	contained	contain	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	factor-kappaB	factor-kappab	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	activator	activator	_	_	_	_	_	_	_
17	protein-1	protein-1	_	_	_	_	_	_	_
18	cognate	cognate	_	_	_	_	_	_	_
19	DNA	dna	_	_	_	_	_	_	_
20	sequences	sequence	_	_	_	_	_	_	_
21	significantly	significantly	_	_	_	_	_	_	_
22	attenuated	attenuate	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	phase	phase	_	_	_	_	_	_	_
25	2	2	_	_	_	_	_	_	_
26	response	response	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	which	which	_	_	_	_	_	_	_
29	implicated	implicate	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	role	role	_	_	_	_	_	_	_
32	for	for	_	_	_	_	_	_	_
33	de	de	_	_	_	_	_	_	_
34	novo	novo	_	_	_	_	_	_	_
35	protein	protein	_	_	_	_	_	_	_
36	synthesis	synthesis	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Surface	surface	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	intercellular	intercellular	_	_	_	_	_	_	_
5	adhesion	adhesion	_	_	_	_	_	_	_
6	molecule-1	molecule-1	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	P-selectin	P-selectin	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	E-selectin	E-selectin	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	HUVECs	HUVEC	_	_	_	_	_	_	_
14	correlated	correlate	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	phase	phase	_	_	_	_	_	_	_
18	1	1	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	2	2	_	_	_	_	_	_	_
21	neutrophil	neutrophil	_	_	_	_	_	_	_
22	adhesion	adhesion	_	_	_	_	_	_	_
23	responses	response	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	demonstrates	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	changes	change	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	endothelial	endothelial	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	GSSG/GSH	gssg/gsh	_	_	_	_	_	_	_
10	cause	cause	_	_	_	_	_	_	_
11	transcription-independent	transcription-independent	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	transcription-dependent	transcription-dependent	_	_	_	_	_	_	_
14	surface	surface	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	different	different	_	_	_	_	_	_	_
18	endothelial	endothelial	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	adhesion	adhesion	_	_	_	_	_	_	_
21	molecules	molecule	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	which	which	_	_	_	_	_	_	_
24	leads	lead	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	2-phase	2-phase	_	_	_	_	_	_	_
28	neutrophil-endothelial	neutrophil-endothelial	_	_	_	_	_	_	_
29	adhesion	adhesion	_	_	_	_	_	_	_
30	response	response	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

